A group of diseases marked by uncontrolled cell growth and potential to spread
The Princess of Wales has an international mission to champion early childhood development, with a two-day visit to Reggio Emilia, Italy. The trip marks her first major international engagement since cancer remission and will explore the Reggio Emilia approach and global models for supporting young children.
Dalglish has confirmed he is undergoing cancer treatment. He has thanked medical staff for their care and discretion, and asked for privacy as he continues treatment. The news follows reports that he inadvertently posted about his health on social media.
The Department of Health is rolling out AI analysis for chest X-rays across NHS trusts by 2029, backed by funding and pilots. Meanwhile, doctors warn about potential liability issues as AI tools assist with diagnosis, demanding robust governance and accountability.
A Japanese approval for Telomelysin offers a gentler option for esophageal cancer patients ineligible for surgery. Other studies show CAR T-cell therapy remains transformative for certain cancers, while nanotechnology and immunotherapies highlight ongoing progress with meaningful patient impact.
A set of recent reports cover long Covid rehabilitation, a Parkinson’s diagnosis for Bruce Foxton of The Jam, and Lyme disease campaigning by a Scottish MSP. Also covered are ulcerative colitis coupled with PSC in a Birmingham mother and ongoing chronic illness advocacy in media.
The Supreme Court has ruled 7-2 that federal pesticide law bars state failure-to-warn lawsuits over Roundup, overturning a $1.25m jury verdict and imperilling thousands of similar claims against Bayer. The decision follows the EPAs position that glyphosate is unlikely to cause cancer and clears the way for dismissal of many pending suits.
England’s children’s mental health referrals have surpassed 1 million for 2024-25, a rise driven by anxiety and suspected autism. Wait times remain long, with more than 60,000 waiting over two years. The report calls for joined-up services across health, education and social care to meet demand.
A coalition of more than 20 states and the District of Columbia has filed suit against CMS over an interim final rule that tightens Medicaid eligibility by redefining medical frailty and enforcing work or community-engagement requirements for expansion enrollees. The suit argues the rule exceeds the agency’s authority, risks disenfranchising patients with serious illnesses, and forces costly system changes as states prepare for a January 2027 rollout.
The UK–US pharmaceutical deal has led to a BMJ analysis predicting the NHS will divert billions to fund new medicines, risking hundreds of thousands of excess deaths by 2036, with the toll higher if social care funding is included.
Nigeria is investigating a fictitious presidential council that allegedly secured 1.3 billion naira in the 2026 budget. Authorities say forged documents created apparent legitimacy, prompting calls for independent inquiry and a government probe.
[Synopsis will be inserted here]
Vivani Medical and Novo Nordisk are exploring a long-acting semaglutide implant to maintain weight loss, potentially replacing frequent injections. The device aims to release medicine steadily for months, pending clinical and regulatory validation.
A national AIHW data report shows cervical cancer incidence is dropping sharply among Australian women aged 25–29, while cancers like bowel cancer rise in their 30s. Vaccination campaigns begun in 2007 and school-based programs contributed to a projected elimination threshold by 2035, though most cancers still affect those 50 and older.
The nuclear test veterans’ case has been reinforced as a two-year MoD review confirms that medical data was withheld, destroyed or missing for decades. Ministers have signalled a path toward reparations and a formal tribunal, while criminal investigations edge forward.
Scotland faces a maternity care crisis with hundreds of deaths in five years. An independent review is announced to inspect culture, rural services and safety, while calls grow for a broader safety remit.
Lauren Laverne has disclosed that she has smouldering myeloma, an asymptomatic blood and bone marrow disorder that can develop into myeloma. She is not currently in treatment and will be monitored with tests while taking a short break from work.
International researchers find inherited genetics influence how cancers evolve after DNA damage, affecting tumour growth and mutation patterns. The Edinburgh-led work, published in Nature, underlines implications for screening, diagnosis and personalised treatment across populations.
Federal SNAP reform has tightened eligibility and shifted costs to states, triggering a sharp drop in participation and putting pressure on food banks. Arizona records the largest decline, with state processes becoming more burdensome and delivery times longer as programs adjust. Projections warn of continued reductions without congressional action.
A round-up of recent cancer-related reports shows patients benefiting from clinical trials and rare misdiagnoses being corrected. From rectal cancer trials in the UK to cervical cancer misdiagnoses under review, readers are kept informed on treatment advances and patient experiences.